Skip to content

Interventional study to evaluate the safety, reliability and validity of the medical device Nimble in comparison to established devices for objective assessment of scar maturation (Cutometer®) and subjective assessment (POSAS) in children after partial deep dermal or full thickness burns

Interventional study to evaluate the safety, reliability and validity of the medical device Nimble in comparison to established devices for objective assessment of scar maturation (Cutometer®) and subjective assessment (POSAS) in children after partial deep dermal or full thickness burns - Nimble – novel objective assessment of scar maturation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00014031
Enrollment
52
Registered
2018-02-12
Start date
2018-02-20
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns, scald (T20-35), scar (L90.5), L90.5 T20-T32

Interventions

Group 1: Arm/Teil A: Measurement of the stiffness of the scar and the adjacent healthy skin with the Nimble and the Cutometer at one timpepoint only (Visite 2). This will be repeated three times, by

Sponsors

Universitätskinderspital Zürich
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 18 Years

Inclusion criteria

Inclusion criteria: Part A: •Male and female patients = 1 y , = 18 y •Scars or transplants resulting from burns = 1month , = 10 years, at any location of the body •Signed Informed consent from the patient or the legally authorized representative --------- Part B •Male and female patients = 1 y , = 18 y •Burn wounds < 3 month ago, not requiring surgical wound coverage but healing with scar tissue, at any location of the body OR •Deep partial thickness and/or full thickness burns < 3 month ago, requiring surgical wound coverage, at any location of the body •Signed Informed consent from the patient or the legally authorized representative

Exclusion criteria

Exclusion criteria: Part A and B: Exclusion criteria: •Patients with known underlying or concomitant medical conditions that may interfere with normal wound healing (e.g. systemic skin and connective tissues diseases, e.g. epidermolysis bullosa or congenital metabolic disease directly influencing wound healing) •Inability to follow the procedures of the study, e.g. due to language problems. •Patients with unhealed wounds at or in the proximity of the measurement sites, persisting at the time of measurements with the interventional device or the control device (Cutometer®). •Enrolment of the Investigator, his/her family members, employees and other dependent persons.

Design outcomes

Primary

MeasureTime frame
Part A: Evaluation of reliability (test-retest, intra-individually, inter-individually) and validity of the Nimble in comparison to the Cutometer® based on: Skin stiffness k (mbar/mm) at the scar/transplant (= 1month, = 10 years) and according healthy skin at one time point. ------------ Part B: Evaluation of scar maturation over time as an assessment of the accordance of the Nimble, the Cutometer® and the POSAS, based on: Skin stiffness k (mbar/mm) at the scar/transplant and according healthy skin using the Nimble, the Cutometer and the POSAS-questionnaire (Patient and Observer Scar Assessment Scale) over the course of 1 year: 3 month, 6 month, 9 month, 12 month.

Secondary

MeasureTime frame
Part A and B: Safety evaluation, as a comparison between the Cutometer® and the Nimble, based on: •Assessment and reporting of all adverse events (expected and unexpected) will be carried out for the full duration of the study.

Countries

Switzerland

Contacts

Public ContactJulia Elrod

UniversitätsSpital Zürich

julia.elrod@kispi.uzh.ch0041 (0) 44 266 7488

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026